| Financial Year |
March 31 2023 |
| Monetary Funds |
252,189,703.03 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
68,689,367.75 |
| Accounts Receivable |
468,154,137.06 |
| Advances to Suppliers |
29,589,075.57 |
| Other Receivables |
14,469,897.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
481,515,096.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
74,794,094.49 |
| Other Current Assets |
26,883,307.82 |
| Total Current Assets |
1,419,342,872.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,190,435.18 |
| Investment Properties |
-- |
| Fixed Assetes |
406,541,648.68 |
| Under-construction Projects |
22,064,871.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,138,216.84 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
121,672,086.91 |
| Other Non-Current Assets |
4,637,444.00 |
| Sub-Total of Non-Current Assets |
1,065,696,505.67 |
| Total Assets |
2,485,039,378.30 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
241,616,561.40 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,428,890.02 |
| Taxes Payable |
6,263,528.00 |
| Interest Payable |
-- |
| Dividend Payable |
90,000.00 |
| Other payables |
68,616,134.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
386,885.07 |
| Sub-Total of Current Liabilities |
581,094,928.04 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
51,109,314.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
51,109,314.59 |
| Total Liabilities |
632,204,242.63 |
| Paid-In Capital(Or Share Stock) |
389,604,420.00 |
| Capital Surplus |
735,559,974.56 |
| Surplus Reserve |
101,370,231.55 |
| LESS:Treasury Stock |
85,409,328.87 |
| Undistributed Profits |
779,845,133.25 |
| Minority Stockholder's Interest |
25,165,720.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,827,669,415.63 |
| Owner's Equity（Stockholder's Equity） |
1,852,835,135.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,485,039,378.30 |
